An observational study in Barrett's Esophagus Without Dysplasia, sponsored by The Guthrie Clinic. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-07.
Sponsored by The Guthrie Clinic · Observational
Among 209 studies in Barrett Esophagus with a site in United States — 38 open to participants now, 48 under way, none of them phase 3. Barrett Esophagus · United States.
Among the 209 studies in Barrett Esophagus with a site in United States, this one is the 73rd largest by planned enrollment of the 86 observational ones that give a count, is one of 14 that started in 2017, is one of 87 observational ones, reaches primary completion later than 11 of the 47 other live ones, and was the 144th registered.
312 studies on the registry are indexed under Barrett Esophagus; 60 are open to participants now.
This study's planned enrollment of 25 is below the median of 144 across 118 observational studies indexed under Barrett Esophagus.
Browse Barrett Esophagus studies →38 of the 209 studies in Barrett Esophagus with a site in United States are open now, in 2 countries. Each count lists the studies.
Of the 44 Barrett Esophagus studies recruiting now, 31 (70%) set no upper age limit and 2 (5%) stop at 75 or younger; 4 take children under 18; 10 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →209 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 14 started in 2017.
Median enrollment 58 across the 122 interventional studies, 123 across the 86 observational. Of the 141 that completed or were terminated, 45 (32%) have results posted.
37 of 209 have an industry lead sponsor. The 10 most frequent:
The Guthrie Clinic is the lead sponsor of 26 studies on the registry; none are open to participants now.
The Guthrie Clinic has 1 study filed under Barrett Esophagus — fewer than ten, so there is no comparison to draw.
14 of the studies in Barrett Esophagus with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06532734Denver Health and Hospital AuthorityBarrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype | 2026-11 |
| NCT00590239Midwest Biomedical Research FoundationBarrett's Esophagus Related Neoplasia (BERN) Project | 2026-11-01 |
| NCT03316053The Guthrie ClinicCell Marker Predictors in Barrett's Esophagus | 2026-12-01 |
| NCT02634645University of Colorado, DenverTREAT-BE Study (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) | 2027-01 |
| NCT05468008AdventHealthEndoscopic Submucosal Dissection (ESD) | 2027-02 |
Among the 209 studies in Barrett Esophagus with a site in United States, from their registry updates:
The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.
Patients with a history of Barrett's esophagus who are scheduled for a routine endoscopy will have an additional biopsy taken for genetic testing.
Patients with a history of Barrett's esophagus
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Biopsy sample
Other: Tissue sample for genetic testing
Tissue sample to be obtained during routine endoscopy
Cell Markers
Identify genes involved in Barrett's Esophagus
Time frame: through study completion, an average of 1 year
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2017 (actual). Primary completion is estimated for Dec 2026, 108 months after the start.
Of 40 observational studies under Barrett Esophagus, half reached primary completion within 252 months of starting (the median), counting those still running; a quarter within 37 and three quarters within 252. This study's planned 108 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Guthrie Clinic